The fluorescence imaging core will provide Harvard Skin Disease Research Center investigators with high resolution localization of fluorescent probes in cells and tissues derived from normal and pathologic materials. Detection of immunofluorescence labels, fluorescent vital dyes and fluorescent fusion proteins are of interest to investigators with diverse experimental approaches that lack expertise in imaging methods.Investigators will be provided with state of the art techniques in biological microscopy including: confocal and multiphoton imaging and fluorescence resonance energy transfer (FRET). Consultative services will be available for immunocytochemistry, in situ hybridization and electron microscopy.
The specific aims of the core are: 1) To provide confocal imaging of live and fixed cells and tissues; allowing the determination of multiple probes within three dimensional organization of cells or tissue and analyzing changes in that distribution over time. 2) To provide multiphoton illumination for imaging of fluorescent probes in live cells, thick tissues or other cases where traditional single photon excitation is insufficient to address investigators' questions. 3) To prbvide fluorescence resonance energy transfer analysis of protein-protein interactions using confocal, multiphoton or wide-field illumination. 4) To provide in-situ hybridization and electron microscopy techniques on a consultative basis. The core contains the necessary equipment, reagents and expertise to conduct advanced biological microscopy experiments. The director and assistant are readily available to advise investigators on all aspects of biological microscopy, fluorescence detection and quantitative imaging.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR042689-12
Application #
7061358
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
12
Fiscal Year
2005
Total Cost
$22,908
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Tian, Tian; Jin, Michelle Qiushuang; Dubin, Krista et al. (2017) IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection. J Immunol 198:4341-4351
Pan, Youdong; Tian, Tian; Park, Chang Ook et al. (2017) Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543:252-256
Volpicelli, Elgida R; Lezcano, Cecilia; Zhan, Qian et al. (2014) The multidrug-resistance transporter ABCB5 is expressed in human placenta. Int J Gynecol Pathol 33:45-51
Guenova, Emmanuella; Watanabe, Rei; Teague, Jessica E et al. (2013) TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res 19:3755-63
Majewska-Szczepanik, Monika; Paust, Silke; von Andrian, Ulrich H et al. (2013) Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-?, interferon-? and interleukin-12. Immunology 140:98-110
Zadran, Sohila; McMickle, Robert; Shackelford, David et al. (2013) Monitoring extra-vascular migratory metastasis (EVMM) of migrating cancer cells using an in vitro co-culture system. Protoc exch 2013:
Burkhardt, Ute E; Hainz, Ursula; Stevenson, Kristen et al. (2013) Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. J Clin Invest 123:3756-65
Dowlatshahi, Mitra; Huang, Victor; Gehad, Ahmed E et al. (2013) Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol 133:1879-89
Seneschal, Julien; Clark, Rachael A; Gehad, Ahmed et al. (2012) Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36:873-84
Girouard, Sasha D; Laga, Alvaro C; Mihm, Martin C et al. (2012) SOX2 contributes to melanoma cell invasion. Lab Invest 92:362-70

Showing the most recent 10 out of 113 publications